Table of Contents United States Metabotropic Glutamate Receptor 5 Market Report 2017 1 Metabotropic Glutamate Receptor 5 Overview 1.1 Product Overview and Scope of Metabotropic Glutamate Receptor 5 1.2 Classification of Metabotropic Glutamate Receptor 5 by Product Category 1.2.1 United States Metabotropic Glutamate Receptor 5 Market Size (Sales Volume) Comparison by Type (2012-2022) 1.2.2 United States Metabotropic Glutamate Receptor 5 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016 1.2.3 Alloswitch-1 1.2.4 BMS-952048 1.2.5 BMS-955829 1.2.6 Dipraglurant ER 1.2.7 Others 1.3 United States Metabotropic Glutamate Receptor 5 Market by Application/End Users 1.3.1 United States Metabotropic Glutamate Receptor 5 Market Size (Consumption) and Market Share Comparison by Application (2012-2022) 1.3.2 Major Depressive Disorder 1.3.3 Alcohol Assiction 1.3.4 Alzheimer's Disease 1.3.5 Others 1.4 United States Metabotropic Glutamate Receptor 5 Market by Region 1.4.1 United States Metabotropic Glutamate Receptor 5 Market Size (Value) Comparison by Region (2012-2022) 1.4.2 The West Metabotropic Glutamate Receptor 5 Status and Prospect (2012-2022) 1.4.3 Southwest Metabotropic Glutamate Receptor 5 Status and Prospect (2012-2022) 1.4.4 The Middle Atlantic Metabotropic Glutamate Receptor 5 Status and Prospect (2012-2022) 1.4.5 New England Metabotropic Glutamate Receptor 5 Status and Prospect (2012-2022) 1.4.6 The South Metabotropic Glutamate Receptor 5 Status and Prospect (2012-2022) 1.4.7 The Midwest Metabotropic Glutamate Receptor 5 Status and Prospect (2012-2022) 1.5 United States Market Size (Value and Volume) of Metabotropic Glutamate Receptor 5 (2012-2022) 1.5.1 United States Metabotropic Glutamate Receptor 5 Sales and Growth Rate (2012-2022) 1.5.2 United States Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2012-2022) 2 United States Metabotropic Glutamate Receptor 5 Market Competition by Players/Suppliers 2.1 United States Metabotropic Glutamate Receptor 5 Sales and Market Share of Key Players/Suppliers (2012-2017) 2.2 United States Metabotropic Glutamate Receptor 5 Revenue and Share by Players/Suppliers (2012-2017) 2.3 United States Metabotropic Glutamate Receptor 5 Average Price by Players/Suppliers (2012-2017) 2.4 United States Metabotropic Glutamate Receptor 5 Market Competitive Situation and Trends 2.4.1 United States Metabotropic Glutamate Receptor 5 Market Concentration Rate 2.4.2 United States Metabotropic Glutamate Receptor 5 Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Metabotropic Glutamate Receptor 5 Manufacturing Base Distribution, Sales Area, Product Type 3 United States Metabotropic Glutamate Receptor 5 Sales (Volume) and Revenue (Value) by Region (2012-2017) 3.1 United States Metabotropic Glutamate Receptor 5 Sales and Market Share by Region (2012-2017) 3.2 United States Metabotropic Glutamate Receptor 5 Revenue and Market Share by Region (2012-2017) 3.3 United States Metabotropic Glutamate Receptor 5 Price by Region (2012-2017) 4 United States Metabotropic Glutamate Receptor 5 Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017) 4.1 United States Metabotropic Glutamate Receptor 5 Sales and Market Share by Type (Product Category) (2012-2017) 4.2 United States Metabotropic Glutamate Receptor 5 Revenue and Market Share by Type (2012-2017) 4.3 United States Metabotropic Glutamate Receptor 5 Price by Type (2012-2017) 4.4 United States Metabotropic Glutamate Receptor 5 Sales Growth Rate by Type (2012-2017) 5 United States Metabotropic Glutamate Receptor 5 Sales (Volume) by Application (2012-2017) 5.1 United States Metabotropic Glutamate Receptor 5 Sales and Market Share by Application (2012-2017) 5.2 United States Metabotropic Glutamate Receptor 5 Sales Growth Rate by Application (2012-2017) 5.3 Market Drivers and Opportunities 6 United States Metabotropic Glutamate Receptor 5 Players/Suppliers Profiles and Sales Data 6.1 Addex Therapeutics Ltd 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 Aevi Genomic Medicine Inc 6.2.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview 6.3 Bristol-Myers Squibb Company 6.3.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Main Business/Business Overview 6.4 Eisai Co Ltd 6.4.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Main Business/Business Overview 6.5 Eli Lilly and Company 6.5.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Main Business/Business Overview 6.6 Heptares Therapeutics Ltd 6.6.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Main Business/Business Overview 6.7 Johnson & Johnson 6.7.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Main Business/Business Overview 6.8 Merz Pharma GmbH & Co KgaA 6.8.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2012-2017) 6.8.4 Main Business/Business Overview 6.9 Novartis AG 6.9.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Main Business/Business Overview 6.10 Richter Gedeon Nyrt 6.10.2 Metabotropic Glutamate Receptor 5 Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2012-2017) 6.10.4 Main Business/Business Overview 6.11 Sumitomo Dainippon Pharma Co Ltd 6.12 Toray Industries Inc 7 Metabotropic Glutamate Receptor 5 Manufacturing Cost Analysis 7.1 Metabotropic Glutamate Receptor 5 Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Metabotropic Glutamate Receptor 5 Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Metabotropic Glutamate Receptor 5 Major Manufacturers in 2016 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Metabotropic Glutamate Receptor 5 Market Size (Value and Volume) Forecast (2017-2022) 11.1 United States Metabotropic Glutamate Receptor 5 Sales Volume, Revenue Forecast (2017-2022) 11.2 United States Metabotropic Glutamate Receptor 5 Sales Volume Forecast by Type (2017-2022) 11.3 United States Metabotropic Glutamate Receptor 5 Sales Volume Forecast by Application (2017-2022) 11.4 United States Metabotropic Glutamate Receptor 5 Sales Volume Forecast by Region (2017-2022) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer

List of Tables and Figures Figure Product Picture of Metabotropic Glutamate Receptor 5 Figure United States Metabotropic Glutamate Receptor 5 Market Size (K Pcs) by Type (2012-2022) Figure United States Metabotropic Glutamate Receptor 5 Sales Volume Market Share by Type (Product Category) in 2016 Figure Alloswitch-1 Product Picture Figure BMS-952048 Product Picture Figure BMS-955829 Product Picture Figure Dipraglurant ER Product Picture Figure Others Product Picture Figure United States Metabotropic Glutamate Receptor 5 Market Size (K Pcs) by Application (2012-2022) Figure United States Sales Market Share of Metabotropic Glutamate Receptor 5 by Application in 2016 Figure Major Depressive Disorder Examples Table Key Downstream Customer in Major Depressive Disorder Figure Alcohol Assiction Examples Table Key Downstream Customer in Alcohol Assiction Figure Alzheimer's Disease Examples Table Key Downstream Customer in Alzheimer's Disease Figure Others Examples Table Key Downstream Customer in Others Figure United States Metabotropic Glutamate Receptor 5 Market Size (Million USD) by Region (2012-2022) Figure The West Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (2012-2022) Figure Southwest Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (2012-2022) Figure The Middle Atlantic Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (2012-2022) Figure New England Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (2012-2022) Figure The South of US Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (2012-2022) Figure The Midwest Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) and Growth Rate (2012-2022) Figure United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate (2012-2022) Figure United States Metabotropic Glutamate Receptor 5 Market Major Players Product Sales Volume (K Pcs) (2012-2017) Table United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) of Key Players/Suppliers (2012-2017) Table United States Metabotropic Glutamate Receptor 5 Sales Share by Players/Suppliers (2012-2017) Figure 2016 United States Metabotropic Glutamate Receptor 5 Sales Share by Players/Suppliers Figure 2017 United States Metabotropic Glutamate Receptor 5 Sales Share by Players/Suppliers Figure United States Metabotropic Glutamate Receptor 5 Market Major Players Product Revenue (Million USD) (2012-2017) Table United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) by Players/Suppliers (2012-2017) Table United States Metabotropic Glutamate Receptor 5 Revenue Share by Players/Suppliers (2012-2017) Figure 2016 United States Metabotropic Glutamate Receptor 5 Revenue Share by Players/Suppliers Figure 2017 United States Metabotropic Glutamate Receptor 5 Revenue Share by Players/Suppliers Table United States Market Metabotropic Glutamate Receptor 5 Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017) Figure United States Market Metabotropic Glutamate Receptor 5 Average Price (USD/Pcs) of Key Players/Suppliers in 2016 Figure United States Metabotropic Glutamate Receptor 5 Market Share of Top 3 Players/Suppliers Figure United States Metabotropic Glutamate Receptor 5 Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Metabotropic Glutamate Receptor 5 Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Metabotropic Glutamate Receptor 5 Product Category Table United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Region (2012-2017) Table United States Metabotropic Glutamate Receptor 5 Sales Share by Region (2012-2017) Figure United States Metabotropic Glutamate Receptor 5 Sales Share by Region (2012-2017) Figure United States Metabotropic Glutamate Receptor 5 Sales Market Share by Region in 2016 Table United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Market Share by Region (2012-2017) Table United States Metabotropic Glutamate Receptor 5 Revenue Share by Region (2012-2017) Figure United States Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2012-2017) Figure United States Metabotropic Glutamate Receptor 5 Revenue Market Share by Region in 2016 Table United States Metabotropic Glutamate Receptor 5 Price (USD/Pcs) by Region (2012-2017) Table United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Type (2012-2017) Table United States Metabotropic Glutamate Receptor 5 Sales Share by Type (2012-2017) Figure United States Metabotropic Glutamate Receptor 5 Sales Share by Type (2012-2017) Figure United States Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2016 Table United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Market Share by Type (2012-2017) Table United States Metabotropic Glutamate Receptor 5 Revenue Share by Type (2012-2017) Figure Revenue Market Share of Metabotropic Glutamate Receptor 5 by Type (2012-2017) Figure Revenue Market Share of Metabotropic Glutamate Receptor 5 by Type in 2016 Table United States Metabotropic Glutamate Receptor 5 Price (USD/Pcs) by Types (2012-2017) Figure United States Metabotropic Glutamate Receptor 5 Sales Growth Rate by Type (2012-2017) Table United States Metabotropic Glutamate Receptor 5 Sales (K Pcs) by Application (2012-2017) Table United States Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2012-2017) Figure United States Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2012-2017) Figure United States Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2016 Table United States Metabotropic Glutamate Receptor 5 Sales Growth Rate by Application (2012-2017) Figure United States Metabotropic Glutamate Receptor 5 Sales Growth Rate by Application (2012-2017) Table Addex Therapeutics Ltd Basic Information List Table Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Growth Rate (2012-2017) Figure Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Market Share in United States (2012-2017) Figure Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Revenue Market Share in United States (2012-2017) Table Aevi Genomic Medicine Inc Basic Information List Table Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales Growth Rate (2012-2017) Figure Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales Market Share in United States (2012-2017) Figure Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Revenue Market Share in United States (2012-2017) Table Bristol-Myers Squibb Company Basic Information List Table Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales Growth Rate (2012-2017) Figure Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales Market Share in United States (2012-2017) Figure Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Revenue Market Share in United States (2012-2017) Table Eisai Co Ltd Basic Information List Table Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales Growth Rate (2012-2017) Figure Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales Market Share in United States (2012-2017) Figure Eisai Co Ltd Metabotropic Glutamate Receptor 5 Revenue Market Share in United States (2012-2017) Table Eli Lilly and Company Basic Information List Table Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales Growth Rate (2012-2017) Figure Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales Market Share in United States (2012-2017) Figure Eli Lilly and Company Metabotropic Glutamate Receptor 5 Revenue Market Share in United States (2012-2017) Table Heptares Therapeutics Ltd Basic Information List Table Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Growth Rate (2012-2017) Figure Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales Market Share in United States (2012-2017) Figure Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Revenue Market Share in United States (2012-2017) Table Johnson & Johnson Basic Information List Table Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales Growth Rate (2012-2017) Figure Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales Market Share in United States (2012-2017) Figure Johnson & Johnson Metabotropic Glutamate Receptor 5 Revenue Market Share in United States (2012-2017) Table Merz Pharma GmbH & Co KgaA Basic Information List Table Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales Growth Rate (2012-2017) Figure Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales Market Share in United States (2012-2017) Figure Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Revenue Market Share in United States (2012-2017) Table Novartis AG Basic Information List Table Novartis AG Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Novartis AG Metabotropic Glutamate Receptor 5 Sales Growth Rate (2012-2017) Figure Novartis AG Metabotropic Glutamate Receptor 5 Sales Market Share in United States (2012-2017) Figure Novartis AG Metabotropic Glutamate Receptor 5 Revenue Market Share in United States (2012-2017) Table Richter Gedeon Nyrt Basic Information List Table Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017) Figure Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales Growth Rate (2012-2017) Figure Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales Market Share in United States (2012-2017) Figure Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Revenue Market Share in United States (2012-2017) Table Sumitomo Dainippon Pharma Co Ltd Basic Information List Table Toray Industries Inc Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Metabotropic Glutamate Receptor 5 Figure Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5 Figure Metabotropic Glutamate Receptor 5 Industrial Chain Analysis Table Raw Materials Sources of Metabotropic Glutamate Receptor 5 Major Players/Suppliers in 2016 Table Major Buyers of Metabotropic Glutamate Receptor 5 Table Distributors/Traders List Figure United States Metabotropic Glutamate Receptor 5 Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022) Figure United States Metabotropic Glutamate Receptor 5 Revenue (Million USD) and Growth Rate Forecast (2017-2022) Figure United States Metabotropic Glutamate Receptor 5 Price (USD/Pcs) Trend Forecast (2017-2022) Table United States Metabotropic Glutamate Receptor 5 Sales Volume (K Pcs) Forecast by Type (2017-2022) Figure United States Metabotropic Glutamate Receptor 5 Sales Volume (K Pcs) Forecast by Type (2017-2022) Figure United States Metabotropic Glutamate Receptor 5 Sales Volume (K Pcs) Forecast by Type in 2022 Table United States Metabotropic Glutamate Receptor 5 Sales Volume (K Pcs) Forecast by Application (2017-2022) Figure United States Metabotropic Glutamate Receptor 5 Sales Volume (K Pcs) Forecast by Application (2017-2022) Figure United States Metabotropic Glutamate Receptor 5 Sales Volume (K Pcs) Forecast by Application in 2022 Table United States Metabotropic Glutamate Receptor 5 Sales Volume (K Pcs) Forecast by Region (2017-2022) Table United States Metabotropic Glutamate Receptor 5 Sales Volume Share Forecast by Region (2017-2022) Figure United States Metabotropic Glutamate Receptor 5 Sales Volume Share Forecast by Region (2017-2022) Figure United States Metabotropic Glutamate Receptor 5 Sales Volume Share Forecast by Region in 2022 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources